Patents by Inventor Wilhelmus Drinkenburg

Wilhelmus Drinkenburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10384070
    Abstract: The present invention provides for eyeglasses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: August 20, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Randall B. Pugh, William Chester Neeley, Robertson Towart, Mario Peeters, Wilhelmus Drinkenburg, Aleksander Miletic
  • Patent number: 9446262
    Abstract: This invention discloses methods and apparatus for providing an ophthalmic lens with light source capable of providing specific bandwidths of light to an eye of a wearer. In some embodiments, an ophthalmic lens is cast molded from a silicone hydrogel and an energy source and light source encapsulated within the ophthalmic lens.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: September 20, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Randall B. Pugh, William Chester Neeley, Robertson Towart, Mario Jozef Joanna Peeters, Wilhelmus Drinkenburg, Aleksandar Miletic
  • Publication number: 20160144149
    Abstract: The present invention provides for eyeglasses used together with contact lenses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. The eyeglass lenses or frames project light into complimentary contact lenses which refract, diffract or reflect light into the wearer's eyes.
    Type: Application
    Filed: February 1, 2016
    Publication date: May 26, 2016
    Inventors: Randall B. PUGH, William C. Neeley, Robertson Towart, Mario J. Peeters, Wilhelmus Drinkenburg, Aleksandar Miletic
  • Patent number: 9248309
    Abstract: The present invention provides for eyeglasses used together with contact lenses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. The eyeglass lenses or frames project light into complimentary contact lenses which refract, diffract or reflect light into the wearer's eyes.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: February 2, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Randall B. Pugh, William Chester Neeley, Robertson Towart, Mario Jozef Joanna Peeters, Wilhelmus Drinkenburg, Aleksandar Miletic
  • Publication number: 20120215291
    Abstract: The present invention provides for eyeglasses used together with contact lenses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. The eyeglass lenses or frames project light into complimentary contact lenses which refract, diffract or reflect light into the wearer's eyes.
    Type: Application
    Filed: January 31, 2012
    Publication date: August 23, 2012
    Inventors: Randall B. Pugh, William Chester Neeley, Robertson Towart, Mario Jozef Joanna Peeters, Wilhelmus Drinkenburg, Aleksandar Miletic
  • Publication number: 20120199995
    Abstract: This invention discloses methods and apparatus for providing an ophthalmic lens with light source capable of providing specific bandwidths of light to an eye of a wearer. In some embodiments, an ophthalmic lens is cast molded from a silicone hydrogel and an energy source and light source encapsulated within the ophthalmic lens.
    Type: Application
    Filed: January 31, 2012
    Publication date: August 9, 2012
    Inventors: Randall B. Pugh, William Chester Neeley, Robertson Towart, Mario Jozef Joanna Peeters, Wilhelmus Drinkenburg, Aleksandar Miletic
  • Publication number: 20120203310
    Abstract: The present invention provides for eyeglasses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses.
    Type: Application
    Filed: January 31, 2012
    Publication date: August 9, 2012
    Inventors: Randall B. Pugh, William Chester Neeley, Robertson Towart, Mario Jozef Joanna Peeters, Wilhelmus Drinkenburg, Aleksandar Miletic
  • Publication number: 20090312416
    Abstract: This invention is directed to a method of treating Excessive daytime Sleepiness (EDS) in a subject, comprising the step of administering a therapeutically effective amount of a compound of Formula (I): Formula (I) or a pharmaceutically acceptable salt or ester thereof wherein Rx is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br and I, alkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, trifluoromethyl, and thioalkoxy containing 1 to 3 carbon atoms; x is an integer of 1 to 3, with the proviso that R may be the same or different when x is 2 or 3; R1 and R2 can be the same or different from each other and are independently selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, aryl, arylalkyl, cycloalkyl of 3 to 7 carbon atoms; R1 and R2 can be joined to form a 5 to 7-membered heterocycle substituted with a member selected from the group consisting of hydrogen, alkyl, and aryl groups, wherein the cyclic
    Type: Application
    Filed: June 7, 2006
    Publication date: December 17, 2009
    Inventors: Abdallah Ahnaou, Wilhelmus Drinkenburg, Joseph Palumbo, Jonathan Sporn
  • Publication number: 20050090488
    Abstract: The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
    Type: Application
    Filed: November 22, 2004
    Publication date: April 28, 2005
    Inventors: John Andrews, Wilhelmus Drinkenburg, Nicholas Ward
  • Patent number: 6835728
    Abstract: The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: December 28, 2004
    Assignee: Akzo Nobel N.V.
    Inventors: John Stuart Andrews, Wilhelmus Drinkenburg, Nicholas Matthew Ward
  • Publication number: 20030105083
    Abstract: The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
    Type: Application
    Filed: October 8, 2002
    Publication date: June 5, 2003
    Inventors: John Stuart Andrews, Wilhelmus Drinkenburg, Nicholas Matthew Ward